Camlin Fine Sciences Limited (NSE:CAMLINFINE)

Market Cap	19.83B -36.0%
Revenue (ttm)	17.78B +7.5%
Net Income	-612.99M
EPS	-3.28
Shares Out	n/a
PE Ratio	n/a
Forward PE	22.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	670,503
Average Volume	572,052
Open	101.00
Previous Close	101.56
Day's Range	97.39 - 103.79
52-Week Range	96.21 - 333.30
Beta	0.22
RSI	27.89
Earnings Date	May 18, 2026

About Camlin Fine Sciences

Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hy...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1931
• Employees: 661
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: CAMLINFINE

Financial Performance

In fiscal year 2025, Camlin Fine Sciences's revenue was 16.67 billion, an increase of 14.62% compared to the previous year's 14.54 billion. Losses were -1.39 billion, 49.9% more than in 2024.